Project Grant HT94252310428
Award Date
9/1/23
Completion Date
8/31/24
Dollars Obligated
$160K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Doylestown, PA 18901, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,191,000 Project Grant to the Baruch S. Blumberg Institute in Doylestown, PA. The grant, which runs from August 1, 2024 to July 31, 2027, supports the institute's research into "Novel Mechanisms Governing Human Breast Cancer Chromosomal Instability." The Baruch S. Blumberg Institute, a non-profit biomedical research organization, will use this funding to conduct innovative scientific...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $564,900.00 to Mayo Clinic to support research aimed at "EXPLOITING VIRAL TROPISM TO TARGET CANCER-ASSOCIATED FIBROBLASTS IN INTRAHEPATIC CHOLANGIOCARCINOMA". The award period runs from September 1, 2024 to August 31, 2026. Mayo Clinic, a renowned non-profit academic medical center, will leverage its expertise in cancer biology, drug development,...
The U.S. Department of Defense, through its Military Medical Research and Development program (CFDA 12.420), awarded a $1,290,499 project grant to the Dana-Farber Cancer Institute, Inc. (DFCI) to enhance the antitumor activity of natural killer cells in ovarian cancer. The 4-year grant, which commenced on September 1, 2024, will support innovative research aimed at developing novel approaches to understanding, detecting, and treating various types of cancer, including ovarian cancer. DFCI, a...
The Department of Defense's Defense Health Agency has awarded a $1,344,002 Project Grant to Cold Spring Harbor Laboratory (CSHL) under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, running from August 1, 2024 to July 31, 2028, will fund research to enhance immunity in colorectal cancer liver metastases. CSHL, a renowned non-profit research institution, will leverage its expertise in cancer biology, genomics, and molecular biology to advance this...
The Defense Health Agency awarded The Broad Institute, Inc. a $987,600 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to target chromophobe renal cell carcinoma with mono- and bi-paratopic antibody drug conjugates. The award period runs from August 1, 2024 to July 31, 2027. As a non-profit research organization, The Broad Institute will leverage its expertise in genomics, proteomics, and computational biology to conduct this innovative biomedical research...
The Defense Health Agency awarded a $1,412,826 Project Grant on September 1, 2023 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research through the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Identification of Risk and Early Detection Biomarkers for Liver Cancer," will support a 3-year study led by Dr. Towia Libermann at Bidmc, with a sub-award to Vanderbilt University Medical Center (VUMC) to assist with case...
The U.S. Defense Health Agency awarded a $700,788 Project Grant to The Institute For Cancer Research, a non-profit subsidiary of Temple University, under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project to study the targeting of the nuclear necroptosis pathway in the pancreatic cancer microenvironment. As a prime grantee, The Institute For Cancer Research will conduct preclinical testing, biomarker analysis, and other specialized...
This federal Project Grant award in the amount of $1,599,743 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research to identify and overcome resistance after donor-derived ex vivo expanded natural killer (NK) cell therapy and haploidentical hematopoietic cell transplantation in children and young adults with high-risk acute myeloid leukemia (AML). The research, conducted by the primary awardee...
The federal Project Grant award of $1,224,997.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cold Spring Harbor Laboratory (CSHL) to conduct research aimed at "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES." This grant, with a performance period from August 1, 2024 to July 31, 2028, will allow CSHL, a renowned non-profit research institution, to leverage its expertise in cancer biology, genomics,...
The Defense Health Agency awarded a $1,116,955 Project Grant to The Broad Institute, Inc. to identify new therapies and therapeutic targets in gastroesophageal cancer. This 3-year grant, running from August 15, 2023 to August 14, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). The Broad Institute, a non-profit biomedical and genomic research organization, will leverage its expertise in areas like genomic sequencing, data analysis, and translational...